Hot Heal Care Stocks To Own For 2019

Facing more than $80,000 in student loan debt, Tiffany Tatafu did what thousands of other student loan borrowers do: She searched for answers on her phone.

The single mother of two had heard that as a public employee, she could be eligible for student loan forgiveness. She’d landed a job as a student support coordinator at Arizona State University after earning a master’s degree in education in 2017.

Tatafu called one of the first listings that came up in her search.

A representative at the company pushed her to sign up for its service, which cost $50 per month for three years on top of her normal student loan payments. They told her it was the only way she’d qualify for forgiveness, Tatafu recalls.

“They definitely made it sound like I had to go through them or I would not be in the program,” Tatafu says. “So they lied.”

Hot Heal Care Stocks To Own For 2019: Gilead Sciences, Inc.(GILD)

Advisors’ Opinion:

  • [By Lee Jackson]

    This stock is trading a very reasonable 10.6 times estimated 2018 earnings. Gilead Sciences Inc. (NASDAQ: GILD) is a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of HIV/AIDS, liver disease, cancer and inflammation. The recent acquisition of KITE allows for entry into the CAR-T space, indicating a renewed focus in oncology.

  • [By Todd Campbell, Keith Speights, and Chuck Saletta]

    It’s not every day that shares in top companies can be bought at a reasonable valuation, so investors ought to pay attention when it happens. For instance, these three Motley Fool contributors believe Gilead Sciences (NASDAQ:GILD), Magellan Health (NASDAQ:MGLN), and Celgene Corp (NASDAQ:CELG) shares represent a unique opportunity to buy leading healthcare companies on sale. Are these stocks a good fit for your portfolio?

  • [By Keith Speights]

    You might be tempted to write off Gilead Sciences (NASDAQ:GILD).

    The once high-flying biotech has lost 45% of its market cap since mid-2015. After the stock climbed more than 20% earlier this year, Gilead lost all of those gains and then some. Sales for the company’s hepatitis C virus (HCV) franchise continue to drop faster than a brick. Gilead’s other drugs can’t generate nearly enough growth to offset the HCV declines.

Hot Heal Care Stocks To Own For 2019: Dynamic Materials Corporation(BOOM)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Dmc Global (NASDAQ:BOOM) was downgraded by research analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a report issued on Thursday.

  • [By Joseph Griffin]

    Dmc Global (NASDAQ:BOOM) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “DMC Global Inc. is a technology company. Its operating sector consists of industrial infrastructure and oilfield products and services. Industrial infrastructure sector is served by DMC’s NobelClad business is a manufacturer of explosion-welded clad metal plates, which are used to fabricate capital equipment. Oilfield products and services sector is served by DynaEnergetics, is a developer, manufacturer and marketer of advanced explosive components and systems used to perforate oil and gas wells. DMC Global Inc. is based in Boulder, Colorado. “

  • [By Motley Fool Transcribers]

    DMC Global Inc.  (NASDAQ:BOOM)Q4 2018 Earnings Conference CallFeb. 21, 2019, 5:00 p.m. ET

    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:


Hot Heal Care Stocks To Own For 2019: CB Financial Services, Inc.(CBFV)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on CB Financial Services (CBFV)

    For more information about research offerings from Zacks Investment Research, visit

  • [By Stephan Byrd]

    CB Financial Services Inc (NASDAQ:CBFV)’s share price hit a new 52-week high and low on Wednesday following a dividend announcement from the company. The company traded as low as $34.95 and last traded at $34.40, with a volume of 4600 shares traded. The stock had previously closed at $34.65.

Leave a Reply

Your email address will not be published. Required fields are marked *